Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects
Open Access
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 70 (5) , 817-825
- https://doi.org/10.1093/ajcn/70.5.817
Abstract
Background: Obesity in hypertensive patients is associated with dyslipidemia and insulin resistance, both of which are improved by weight control. n−3 Fatty acids have diverse effects on mechanisms underlying atherosclerosis, including a decrease in serum triacylglycerols and an increase in HDL2 cholesterol. Objective: The objective was to examine whether dietary fish enhances the effects of weight loss on serum lipids, glucose, and insulin in 69 overweight, treated hypertensive patients. Design: Overweight patients being treated for hypertension were randomly assigned to either a daily fish meal (3.65 g n−3 fatty acids), a weight-loss regimen, the 2 regimens combined, or a control group for 16 wk. Results: Sixty-three subjects completed the study. Weight decreased by a mean (±SEM) of 5.6 ± 0.8 kg with energy restriction. Weight loss decreased fasting insulin (P = 0.003) and the area under the curve for insulin (P = 0.003) and glucose (P = 0.047) during an oral-glucose-tolerance test. The greatest decrease occurred in the fish + weight-loss group. There was no independent effect of fish on glucose or insulin. Fish increased HDL2 cholesterol (P = 0.004) and decreased HDL3 cholesterol (P = 0.026) without altering total, LDL, or HDL cholesterol. Weight loss had no effect on these variables. Fasting triacylglycerols fell significantly with fish consumption (29%) and weight loss (26%). The fish + weight-loss group showed the greatest improvement in lipids: triacylglycerols decreased by 38% (P < 0.001) and HDL2 cholesterol increased by 24% (P = 0.04) compared with the control group. Conclusions: Incorporating a daily fish meal into a weight-loss regimen was more effective than either measure alone at improving glucose-insulin metabolism and dyslipidemia. Cardiovascular risk is likely to be substantially reduced in overweight hypertensive patients with a weight-loss program incorporating fish meals rich in n−3 fatty acids.Keywords
This publication has 58 references indexed in Scilit:
- Insulin and hypertension: a causal relationship?Cardiovascular Research, 1996
- Glucose and Insulin Metabolism in HypertensionAmerican Journal of Nephrology, 1996
- Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease.Hypertension, 1993
- Dietary Fish Oil and Insulin Action in HumansAnnals of the New York Academy of Sciences, 1993
- Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men.Hypertension, 1992
- Supplementation with n‐3 fatty acids reduces triglycerides but increases PAI‐1 in non‐insulin‐dependent diabetes mellitusEuropean Journal of Clinical Investigation, 1992
- Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in HypertensionNew England Journal of Medicine, 1990
- The Antihypertensive Effects of Fish OilNew England Journal of Medicine, 1989
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Influence of weight reduction on plasma lipoproteins in obese patients.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983